Compare ADNT & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADNT | ATRC |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | ADNT | ATRC |
|---|---|---|
| Price | $18.89 | $39.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $22.11 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.3M | 530.9K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,535,000,000.00 | $518,304,999.00 |
| Revenue This Year | $0.98 | $16.90 |
| Revenue Next Year | $2.62 | $12.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $10.04 | $28.29 |
| 52 Week High | $26.16 | $43.11 |
| Indicator | ADNT | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 39.42 | 65.81 |
| Support Level | $18.76 | $34.88 |
| Resistance Level | $19.76 | $38.90 |
| Average True Range (ATR) | 0.79 | 1.84 |
| MACD | 0.11 | 0.46 |
| Stochastic Oscillator | 39.49 | 98.37 |
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.